Literature DB >> 35426000

Evaluation of salivary and serum methylated arginine metabolites and nitric oxide synthase in advanced periodontitis patients.

Volkan Şengül1, Zeliha Güney2, Şivge Kurgan3, Canan Önder1, Muhittin A Serdar4, Meral Günhan1.   

Abstract

OBJECTIVES: Methylated arginine metabolites and nitric oxide synthase (NOS) play a critical role in regulating endothelial function. The aim of this study was to determine levels of NOS, and methylated arginine metabolites (ADMA, SDMA, homoarginine, arginine, and L-NMMA) and IL-6 in serum and saliva in patients with advanced periodontal diseases and identify their association with clinical parameters.
MATERIALS AND METHODS: The study consisted of two groups: healthy individuals (control: n = 24), and generalized Stage III Grade B periodontitis (P: n = 21). Clinical periodontal parameters (probing pocket depth, bleeding on probing, clinical attachment level) were recorded. IL 6 and NOS levels in saliva and serum were analyzed by enzyme-linked immunosorbent assay (ELISA). ADMA, SDMA, homoArg, arginine, and L-NMMA in saliva and serum were analyzed by liquid chromatography-mass spectrometry (LC MS/MS).
RESULTS: Clinical parameters were significantly higher in the periodontitis group (p < 0.001). In periodontitis group, NOS, ADMA, and arginine levels in saliva were statistically significantly higher than control group (p < 0.05). Serum levels of SDMA were statistically significantly lower, and IL-6 was statistically significantly higher in P group than C group (p < 0.05). ADMA, NOS, and arginine levels were significantly positive correlated with all clinical periodontal parameters (p < 0.05).
CONCLUSIONS: These findings suggest that there is a relationship between severity of periodontal disease and endothelial dysfunction by means of ADMA. Salivary ADMA may be related with periodontal inflammation. CLINICAL RELEVANCE: ADMA levels in periodontal inflammation are associated with endothelial dysfunction. According to the results of our study, periodontal inflammation is effective on both local and systemic methylated arginine metabolites and nitric oxide synthase levels. This may shed light on the relationship between periodontal disease and systemic status.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  (MeSH): Asymmetric dimethylarginine (ADMA); Nitric oxide synthase (NOS); Periodontitis

Mesh:

Substances:

Year:  2022        PMID: 35426000     DOI: 10.1007/s00784-022-04479-w

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.606


  47 in total

Review 1.  Mammalian nitric oxide synthases.

Authors:  D J Stuehr; O W Griffith
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1992

Review 2.  Nitric oxide, a novel biologic messenger.

Authors:  C J Lowenstein; S H Snyder
Journal:  Cell       Date:  1992-09-04       Impact factor: 41.582

3.  The role of homocysteine, asymmetric dimethylarginine and nitric oxide in pre-eclampsia.

Authors:  B Demir; S Demir; S Pasa; S Guven; Y Atamer; A Atamer; Y Kocyigit
Journal:  J Obstet Gynaecol       Date:  2012-08       Impact factor: 1.246

Review 4.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

Review 5.  Nitric oxide synthase in innate and adaptive immunity: an update.

Authors:  Christian Bogdan
Journal:  Trends Immunol       Date:  2015-02-13       Impact factor: 16.687

Review 6.  Endothelium microenvironment sensing leading to nitric oxide mediated vasodilation: a review of nervous and biomechanical signals.

Authors:  Alfred Quillon; Bérengère Fromy; Romain Debret
Journal:  Nitric Oxide       Date:  2015-01-28       Impact factor: 4.427

7.  Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator.

Authors:  J P Cooke; E Rossitch; N A Andon; J Loscalzo; V J Dzau
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

Review 8.  Nitric oxide: a physiologic messenger.

Authors:  C J Lowenstein; J L Dinerman; S H Snyder
Journal:  Ann Intern Med       Date:  1994-02-01       Impact factor: 25.391

Review 9.  Strategies to increase nitric oxide signalling in cardiovascular disease.

Authors:  Jon O Lundberg; Mark T Gladwin; Eddie Weitzberg
Journal:  Nat Rev Drug Discov       Date:  2015-08-07       Impact factor: 84.694

Review 10.  Nitric oxide. A novel signal transduction mechanism for transcellular communication.

Authors:  L J Ignarro
Journal:  Hypertension       Date:  1990-11       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.